Global Viral Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Viral vector-based gene therapy drugs are pharmaceutical products that use viral vectors to deliver therapeutic genes into target cells for the treatment of genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects.
The global Viral Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Viral Vector-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world Viral Vector-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Vector-Based Gene Therapy Drugs sales for 2023 through 2029. With Viral Vector-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Viral Vector-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector-Based Gene Therapy Drugs.
United States market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Viral Vector-Based Gene Therapy Drugs players cover GSK, MolMed, GILD, JW Therapeutics, Sibiono, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Viral vector-based gene therapy drugs are pharmaceutical products that use viral vectors to deliver therapeutic genes into target cells for the treatment of genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects.
The global Viral Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Viral Vector-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world Viral Vector-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Vector-Based Gene Therapy Drugs sales for 2023 through 2029. With Viral Vector-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Viral Vector-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector-Based Gene Therapy Drugs.
United States market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Viral Vector-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Viral Vector-Based Gene Therapy Drugs players cover GSK, MolMed, GILD, JW Therapeutics, Sibiono, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Retroviral Vector
- Adenovirus Vector
- Lentiviral Vector
- Others
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Retroviral Vector
- Adenovirus Vector
- Lentiviral Vector
- Others
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- MolMed
- GILD
- JW Therapeutics
- Sibiono
- Latima
- Novartis
- Bluebird Bio
- Thermo Fisher Scientific
- Intas
- BMS
- Orchard Therapeutics
- Shanghai Sunway Biotech
- uniQure
- Spark Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vector-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Viral Vector-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Viral Vector-Based Gene Therapy Drugs Segment by Type
2.2.1 Retroviral Vector
2.2.2 Adenovirus Vector
2.2.3 Lentiviral Vector
2.2.4 Others
2.3 Viral Vector-Based Gene Therapy Drugs Market Size by Type
2.3.1 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Viral Vector-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Viral Vector-Based Gene Therapy Drugs Market Size by Application
2.5.1 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 VIRAL VECTOR-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Viral Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR-BASED GENE THERAPY DRUGS BY REGION
4.1 Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Viral Vector-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vector-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL VECTOR-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Viral Vector-Based Gene Therapy Drugs Forecast
10.1.3 APAC Viral Vector-Based Gene Therapy Drugs Forecast
10.1.4 Europe Viral Vector-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Forecast
10.2 Americas Viral Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3 APAC Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Viral Vector-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.5 India Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4 Europe Viral Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.2 France Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.3 UK Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market Viral Vector-Based Gene Therapy Drugs Forecast
10.6 Global Viral Vector-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Viral Vector-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Viral Vector-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Viral Vector-Based Gene Therapy Drugs Product Offered
11.1.3 GSK Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 MolMed
11.2.1 MolMed Company Information
11.2.2 MolMed Viral Vector-Based Gene Therapy Drugs Product Offered
11.2.3 MolMed Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 MolMed Main Business Overview
11.2.5 MolMed Latest Developments
11.3 GILD
11.3.1 GILD Company Information
11.3.2 GILD Viral Vector-Based Gene Therapy Drugs Product Offered
11.3.3 GILD Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GILD Main Business Overview
11.3.5 GILD Latest Developments
11.4 JW Therapeutics
11.4.1 JW Therapeutics Company Information
11.4.2 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.4.3 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 JW Therapeutics Main Business Overview
11.4.5 JW Therapeutics Latest Developments
11.5 Sibiono
11.5.1 Sibiono Company Information
11.5.2 Sibiono Viral Vector-Based Gene Therapy Drugs Product Offered
11.5.3 Sibiono Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sibiono Main Business Overview
11.5.5 Sibiono Latest Developments
11.6 Latima
11.6.1 Latima Company Information
11.6.2 Latima Viral Vector-Based Gene Therapy Drugs Product Offered
11.6.3 Latima Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Latima Main Business Overview
11.6.5 Latima Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Viral Vector-Based Gene Therapy Drugs Product Offered
11.7.3 Novartis Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Information
11.8.2 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product Offered
11.8.3 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bluebird Bio Main Business Overview
11.8.5 Bluebird Bio Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product Offered
11.9.3 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Intas
11.10.1 Intas Company Information
11.10.2 Intas Viral Vector-Based Gene Therapy Drugs Product Offered
11.10.3 Intas Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Intas Main Business Overview
11.10.5 Intas Latest Developments
11.11 BMS
11.11.1 BMS Company Information
11.11.2 BMS Viral Vector-Based Gene Therapy Drugs Product Offered
11.11.3 BMS Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 BMS Main Business Overview
11.11.5 BMS Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.12.3 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Shanghai Sunway Biotech
11.13.1 Shanghai Sunway Biotech Company Information
11.13.2 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product Offered
11.13.3 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shanghai Sunway Biotech Main Business Overview
11.13.5 Shanghai Sunway Biotech Latest Developments
11.14 uniQure
11.14.1 uniQure Company Information
11.14.2 uniQure Viral Vector-Based Gene Therapy Drugs Product Offered
11.14.3 uniQure Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 uniQure Main Business Overview
11.14.5 uniQure Latest Developments
11.15 Spark Therapeutics
11.15.1 Spark Therapeutics Company Information
11.15.2 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.15.3 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Spark Therapeutics Main Business Overview
11.15.5 Spark Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vector-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Viral Vector-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Viral Vector-Based Gene Therapy Drugs Segment by Type
2.2.1 Retroviral Vector
2.2.2 Adenovirus Vector
2.2.3 Lentiviral Vector
2.2.4 Others
2.3 Viral Vector-Based Gene Therapy Drugs Market Size by Type
2.3.1 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Viral Vector-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Viral Vector-Based Gene Therapy Drugs Market Size by Application
2.5.1 Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 VIRAL VECTOR-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Viral Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR-BASED GENE THERAPY DRUGS BY REGION
4.1 Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Viral Vector-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vector-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL VECTOR-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Viral Vector-Based Gene Therapy Drugs Forecast
10.1.3 APAC Viral Vector-Based Gene Therapy Drugs Forecast
10.1.4 Europe Viral Vector-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Forecast
10.2 Americas Viral Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market Viral Vector-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3 APAC Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Viral Vector-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.5 India Market Viral Vector-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4 Europe Viral Vector-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.2 France Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.3 UK Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market Viral Vector-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa Viral Vector-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market Viral Vector-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market Viral Vector-Based Gene Therapy Drugs Forecast
10.6 Global Viral Vector-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Viral Vector-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Viral Vector-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Viral Vector-Based Gene Therapy Drugs Product Offered
11.1.3 GSK Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 MolMed
11.2.1 MolMed Company Information
11.2.2 MolMed Viral Vector-Based Gene Therapy Drugs Product Offered
11.2.3 MolMed Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 MolMed Main Business Overview
11.2.5 MolMed Latest Developments
11.3 GILD
11.3.1 GILD Company Information
11.3.2 GILD Viral Vector-Based Gene Therapy Drugs Product Offered
11.3.3 GILD Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GILD Main Business Overview
11.3.5 GILD Latest Developments
11.4 JW Therapeutics
11.4.1 JW Therapeutics Company Information
11.4.2 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.4.3 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 JW Therapeutics Main Business Overview
11.4.5 JW Therapeutics Latest Developments
11.5 Sibiono
11.5.1 Sibiono Company Information
11.5.2 Sibiono Viral Vector-Based Gene Therapy Drugs Product Offered
11.5.3 Sibiono Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sibiono Main Business Overview
11.5.5 Sibiono Latest Developments
11.6 Latima
11.6.1 Latima Company Information
11.6.2 Latima Viral Vector-Based Gene Therapy Drugs Product Offered
11.6.3 Latima Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Latima Main Business Overview
11.6.5 Latima Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Viral Vector-Based Gene Therapy Drugs Product Offered
11.7.3 Novartis Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Information
11.8.2 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product Offered
11.8.3 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bluebird Bio Main Business Overview
11.8.5 Bluebird Bio Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product Offered
11.9.3 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Intas
11.10.1 Intas Company Information
11.10.2 Intas Viral Vector-Based Gene Therapy Drugs Product Offered
11.10.3 Intas Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Intas Main Business Overview
11.10.5 Intas Latest Developments
11.11 BMS
11.11.1 BMS Company Information
11.11.2 BMS Viral Vector-Based Gene Therapy Drugs Product Offered
11.11.3 BMS Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 BMS Main Business Overview
11.11.5 BMS Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.12.3 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Shanghai Sunway Biotech
11.13.1 Shanghai Sunway Biotech Company Information
11.13.2 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product Offered
11.13.3 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shanghai Sunway Biotech Main Business Overview
11.13.5 Shanghai Sunway Biotech Latest Developments
11.14 uniQure
11.14.1 uniQure Company Information
11.14.2 uniQure Viral Vector-Based Gene Therapy Drugs Product Offered
11.14.3 uniQure Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 uniQure Main Business Overview
11.14.5 uniQure Latest Developments
11.15 Spark Therapeutics
11.15.1 Spark Therapeutics Company Information
11.15.2 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
11.15.3 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Spark Therapeutics Main Business Overview
11.15.5 Spark Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Viral Vector-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Retroviral Vector
Table 4. Major Players of Adenovirus Vector
Table 5. Major Players of Lentiviral Vector
Table 6. Major Players of Others
Table 7. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 10. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 15. Viral Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 16. Viral Vector-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 21. Global Viral Vector-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Viral Vector-Based Gene Therapy Drugs
Table 41. Key Market Challenges & Risks of Viral Vector-Based Gene Therapy Drugs
Table 42. Key Industry Trends of Viral Vector-Based Gene Therapy Drugs
Table 43. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. GSK Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 48. GSK Viral Vector-Based Gene Therapy Drugs Product Offered
Table 49. GSK Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. GSK Main Business
Table 51. GSK Latest Developments
Table 52. MolMed Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 53. MolMed Viral Vector-Based Gene Therapy Drugs Product Offered
Table 54. MolMed Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. MolMed Main Business
Table 56. MolMed Latest Developments
Table 57. GILD Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 58. GILD Viral Vector-Based Gene Therapy Drugs Product Offered
Table 59. GILD Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GILD Main Business
Table 61. GILD Latest Developments
Table 62. JW Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 63. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 64. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. JW Therapeutics Main Business
Table 66. JW Therapeutics Latest Developments
Table 67. Sibiono Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 68. Sibiono Viral Vector-Based Gene Therapy Drugs Product Offered
Table 69. Sibiono Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sibiono Main Business
Table 71. Sibiono Latest Developments
Table 72. Latima Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 73. Latima Viral Vector-Based Gene Therapy Drugs Product Offered
Table 74. Latima Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Latima Main Business
Table 76. Latima Latest Developments
Table 77. Novartis Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 78. Novartis Viral Vector-Based Gene Therapy Drugs Product Offered
Table 79. Novartis Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Bluebird Bio Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 83. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product Offered
Table 84. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bluebird Bio Main Business
Table 86. Bluebird Bio Latest Developments
Table 87. Thermo Fisher Scientific Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 88. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product Offered
Table 89. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Thermo Fisher Scientific Main Business
Table 91. Thermo Fisher Scientific Latest Developments
Table 92. Intas Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 93. Intas Viral Vector-Based Gene Therapy Drugs Product Offered
Table 94. Intas Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Intas Main Business
Table 96. Intas Latest Developments
Table 97. BMS Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 98. BMS Viral Vector-Based Gene Therapy Drugs Product Offered
Table 99. BMS Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. BMS Main Business
Table 101. BMS Latest Developments
Table 102. Orchard Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 103. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 104. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Orchard Therapeutics Main Business
Table 106. Orchard Therapeutics Latest Developments
Table 107. Shanghai Sunway Biotech Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 108. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product Offered
Table 109. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Shanghai Sunway Biotech Main Business
Table 111. Shanghai Sunway Biotech Latest Developments
Table 112. uniQure Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 113. uniQure Viral Vector-Based Gene Therapy Drugs Product Offered
Table 114. uniQure Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. uniQure Main Business
Table 116. uniQure Latest Developments
Table 117. Spark Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 118. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 119. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Spark Therapeutics Main Business
Table 121. Spark Therapeutics Latest Developments
Table 1. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Viral Vector-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Retroviral Vector
Table 4. Major Players of Adenovirus Vector
Table 5. Major Players of Lentiviral Vector
Table 6. Major Players of Others
Table 7. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 10. Viral Vector-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 15. Viral Vector-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 16. Viral Vector-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 21. Global Viral Vector-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Viral Vector-Based Gene Therapy Drugs
Table 41. Key Market Challenges & Risks of Viral Vector-Based Gene Therapy Drugs
Table 42. Key Industry Trends of Viral Vector-Based Gene Therapy Drugs
Table 43. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Viral Vector-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. GSK Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 48. GSK Viral Vector-Based Gene Therapy Drugs Product Offered
Table 49. GSK Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. GSK Main Business
Table 51. GSK Latest Developments
Table 52. MolMed Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 53. MolMed Viral Vector-Based Gene Therapy Drugs Product Offered
Table 54. MolMed Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. MolMed Main Business
Table 56. MolMed Latest Developments
Table 57. GILD Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 58. GILD Viral Vector-Based Gene Therapy Drugs Product Offered
Table 59. GILD Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GILD Main Business
Table 61. GILD Latest Developments
Table 62. JW Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 63. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 64. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. JW Therapeutics Main Business
Table 66. JW Therapeutics Latest Developments
Table 67. Sibiono Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 68. Sibiono Viral Vector-Based Gene Therapy Drugs Product Offered
Table 69. Sibiono Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sibiono Main Business
Table 71. Sibiono Latest Developments
Table 72. Latima Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 73. Latima Viral Vector-Based Gene Therapy Drugs Product Offered
Table 74. Latima Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Latima Main Business
Table 76. Latima Latest Developments
Table 77. Novartis Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 78. Novartis Viral Vector-Based Gene Therapy Drugs Product Offered
Table 79. Novartis Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Bluebird Bio Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 83. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product Offered
Table 84. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bluebird Bio Main Business
Table 86. Bluebird Bio Latest Developments
Table 87. Thermo Fisher Scientific Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 88. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product Offered
Table 89. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Thermo Fisher Scientific Main Business
Table 91. Thermo Fisher Scientific Latest Developments
Table 92. Intas Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 93. Intas Viral Vector-Based Gene Therapy Drugs Product Offered
Table 94. Intas Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Intas Main Business
Table 96. Intas Latest Developments
Table 97. BMS Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 98. BMS Viral Vector-Based Gene Therapy Drugs Product Offered
Table 99. BMS Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. BMS Main Business
Table 101. BMS Latest Developments
Table 102. Orchard Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 103. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 104. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Orchard Therapeutics Main Business
Table 106. Orchard Therapeutics Latest Developments
Table 107. Shanghai Sunway Biotech Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 108. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product Offered
Table 109. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Shanghai Sunway Biotech Main Business
Table 111. Shanghai Sunway Biotech Latest Developments
Table 112. uniQure Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 113. uniQure Viral Vector-Based Gene Therapy Drugs Product Offered
Table 114. uniQure Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. uniQure Main Business
Table 116. uniQure Latest Developments
Table 117. Spark Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Drugs Area Served and Its Competitors
Table 118. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product Offered
Table 119. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Spark Therapeutics Main Business
Table 121. Spark Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Viral Vector-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Viral Vector-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Viral Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Viral Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Viral Vector-Based Gene Therapy Drugs in Hospital
Figure 11. Global Viral Vector-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Viral Vector-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global Viral Vector-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. Viral Vector-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global Viral Vector-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. Viral Vector-Based Gene Therapy Drugs in Others
Figure 17. Global Viral Vector-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas Viral Vector-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Viral Vector-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Viral Vector-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Viral Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Viral Vector-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Viral Vector-Based Gene Therapy Drugs in Hospital
Figure 11. Global Viral Vector-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Viral Vector-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global Viral Vector-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. Viral Vector-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global Viral Vector-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. Viral Vector-Based Gene Therapy Drugs in Others
Figure 17. Global Viral Vector-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas Viral Vector-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Viral Vector-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Viral Vector-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Viral Vector-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
